MD

Business Context and Reporting Period

Company: Pediatrix Medical Group, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2004
Business Overview: The Company operates as a management company for pediatric medical practices, including neonatal intensive care, maternal-fetal medicine, and general pediatrics. The reporting period includes the results of two physician group practices acquired during the quarter and a metabolic screening laboratory acquired in 2003.

Key Financial Metrics

Note: Working Capital calculated as Current Assets ($141,920) minus Current Liabilities ($78,149). Total Debt includes current portion of long-term debt ($652) and long-term debt ($1,394).

Material Changes vs. Prior Period

• Revenue Growth: Net patient service revenue increased 17.4% ($21.9 million). Approximately 44.7% of this increase was driven by acquisitions and new hospital contracts, while same-unit revenue grew 9.7% due to increased patient days and billing code modifications.
• Expense Increases: Practice salaries and benefits rose 15.9% ($11.9 million) due to new staff for acquisitions, volume growth, and higher incentive compensation. Practice supplies increased 31.6% primarily due to the metabolic screening laboratory.
• Profitability: Operating margin improved to 23.0% from 21.8% in the prior year, driven by a reduction in general and administrative expenses as a percentage of revenue.
• Cash Flow: Net cash used in operating activities was $7.9 million, compared to $6.5 million in the prior year. This seasonal outflow is attributed to the timing of annual incentive compensation and 401(k) matching payments.
• Acquisitions: The Company spent approximately $8.7 million in cash to acquire two physician group practices during the quarter.

Guidance, Outlook, and Risks

• Liquidity: The Company maintains a $100 million revolving line of credit maturing in August 2004. No principal balance was outstanding as of March 31, 2004, though $6.5 million was utilized for letters of credit. Management anticipates sufficient funds from operations and cash on hand to meet obligations for the next 12 months.
• Legal and Regulatory Contingencies:
  • FTC Investigation: An ongoing investigation regarding competition issues related to the 2001 acquisition of Magella Healthcare Corporation and general business practices.
  • Medicaid/TRICARE Investigations: Active federal and state investigations into billing practices for Medicaid and TRICARE programs. A search warrant was served in November 2003 regarding a Las Vegas practice.
  • Malpractice: The Company is subject to medical malpractice claims and indemnification obligations. While management believes current insurance is adequate, future coverage availability and costs are uncertain.
• Subsequent Events: Following the quarter-end, the Company completed the acquisition of three additional physician group practices for approximately $18.3 million in cash.

Investor Verification Checklist

• Regulatory Outcomes: Monitor the status and potential financial impact of the ongoing FTC, Medicaid, and TRICARE investigations.
• Debt Maturity: Verify the status of the $100 million line of credit maturing in August 2004 and the progress of the proposed syndication of a new facility.
• Acquisition Integration: Assess the financial performance of the two practices acquired in Q1 2004 and the three acquired subsequently.
• Insurance Costs: Track renewal terms and premium costs for professional liability insurance, which impacts operating margins.
• Stock-Based Compensation: Note that reported net income does not reflect fair-value stock-based compensation; pro forma net income would be lower ($19.2 million for Q1 2004).